Endovia Health Sciences, Inc.
EDVA· NYSE
Filed Aug 19, 2014 · 10-Q · 50 days after period end · 0001079973-14-000451
| Metric | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|
| Revenue | $143.20K | $82.37K | $79.22K |
| Net Income | -$5.10K | -$7.04K | $7.64K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Aug 19, 2014 · 50 d after period end